Follow
Subrata Ghosh
Subrata Ghosh
APC Microbiome Ireland, College of Medicine and Health, University College Cork, ireland,
Verified email at ucc.ie - Homepage
Title
Cited by
Cited by
Year
Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review
NA Molodecky, S Soon, DM Rabi, WA Ghali, M Ferris, G Chernoff, ...
Gastroenterology 142 (1), 46-54. e42, 2012
62592012
Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies
SC Ng, HY Shi, N Hamidi, FE Underwood, W Tang, EI Benchimol, ...
The Lancet 390 (10114), 2769-2778, 2017
58502017
Ustekinumab as induction and maintenance therapy for Crohn’s disease
BG Feagan, WJ Sandborn, C Gasink, D Jacobstein, Y Lang, JR Friedman, ...
New England journal of medicine 375 (20), 1946-1960, 2016
19022016
Ustekinumab induction and maintenance therapy in refractory Crohn's disease
WJ Sandborn, C Gasink, LL Gao, MA Blank, J Johanns, C Guzzo, ...
New England Journal of Medicine 367 (16), 1519-1528, 2012
12922012
Combination therapy with infliximab and azathioprine is superior to monotherapy with either agent in ulcerative colitis
R Panaccione, S Ghosh, S Middleton, JR Márquez, BB Scott, L Flint, ...
Gastroenterology 146 (2), 392-400. e3, 2014
11122014
Natalizumab for active Crohn's disease
S Ghosh, E Goldin, FH Gordon, HA Malchow, J Rask-Madsen, ...
New England Journal of Medicine 348 (1), 24-32, 2003
10082003
Risk of surgery for inflammatory bowel diseases has decreased over time: a systematic review and meta-analysis of population-based studies
AD Frolkis, J Dykeman, ME Negrón, J Debruyn, N Jette, KM Fiest, ...
Gastroenterology 145 (5), 996-1006, 2013
9402013
Tofacitinib, an oral Janus kinase inhibitor, in active ulcerative colitis
WJ Sandborn, S Ghosh, J Panes, I Vranic, C Su, S Rousell, ...
New England Journal of Medicine 367 (7), 616-624, 2012
9292012
European evidence-based consensus on the management of ulcerative colitis: current management
SPL Travis, EF Stange, M Lémann, T Øresland, WA Bemelman, ...
Journal of Crohn's and Colitis 2 (1), 24-62, 2008
7392008
The global incidence of appendicitis: a systematic review of population-based studies
M Ferris, S Quan, BS Kaplan, N Molodecky, CG Ball, GW Chernoff, ...
Annals of surgery 266 (2), 237-241, 2017
7252017
Increased capsaicin receptor TRPV1-expressing sensory fibres in irritable bowel syndrome and their correlation with abdominal pain
A Akbar, Y Yiangou, P Facer, JRF Walters, P Anand, S Ghosh
Gut 57 (7), 923-929, 2008
6652008
Ozanimod induction and maintenance treatment for ulcerative colitis
WJ Sandborn, BG Feagan, DC Wolf, G D’Haens, S Vermeire, SB Hanauer, ...
New England Journal of Medicine 374 (18), 1754-1762, 2016
5042016
NLRP3 inflammasome plays a key role in the regulation of intestinal homeostasis
SA Hirota, J Ng, A Lueng, M Khajah, K Parhar, Y Li, V Lam, MS Potentier, ...
Inflammatory bowel diseases 17 (6), 1359-1372, 2011
5032011
Infliximab in moderately severe glucocorticoid resistant ulcerative colitis: a randomised controlled trial
CSJ Probert, SD Hearing, S Schreiber, T Kühbacher, S Ghosh, IDR Arnott, ...
Gut 52 (7), 998-1002, 2003
4712003
Muramyl dipeptide and toll-like receptor sensitivity in NOD2-associated Crohn's disease
DA van Heel, S Ghosh, M Butler, KA Hunt, AMC Lundberg, T Ahmad, ...
The Lancet 365 (9473), 1794-1796, 2005
4102005
Impact of inflammatory bowel disease on quality of life: Results of the European Federation of Crohn's and Ulcerative Colitis Associations (EFCCA) patient survey
S Ghosh, R Mitchell
Journal of Crohn's and Colitis 1 (1), 10-20, 2007
4092007
Inflammatory bowel disease: a Canadian burden of illness review
A Rocchi, EI Benchimol, CN Bernstein, A Bitton, B Feagan, R Panaccione, ...
Canadian Journal of Gastroenterology and Hepatology 26 (11), 811-817, 2012
3902012
The inflammatory bowel diseases and ambient air pollution: a novel association
GG Kaplan, J Hubbard, J Korzenik, BE Sands, R Panaccione, S Ghosh, ...
Official journal of the American College of Gastroenterology| ACG 105 (11 …, 2010
3672010
A phase 2 study of tofacitinib, an oral Janus kinase inhibitor, in patients with Crohn’s disease
WJ Sandborn, S Ghosh, J Panes, I Vranic, W Wang, W Niezychowski, ...
Clinical gastroenterology and hepatology 12 (9), 1485-1493. e2, 2014
3482014
Low bone mineral density in Crohn's disease, but not in ulcerative colitis, at diagnosis
S Ghosh, S Cowen, WJ Hannan, A Ferguson
Gastroenterology 107 (4), 1031-1039, 1994
3311994
The system can't perform the operation now. Try again later.
Articles 1–20